Two Sigma Securities’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,129
Closed -$25.5K 1449
2024
Q4
$25.5K Buy
16,129
+2,402
+17% +$3.36K ﹤0.01% 1276
2024
Q3
$17K Buy
+13,727
New +$17.3K ﹤0.01% 2523
2024
Q1
Sell
-12,798
Closed -$33.5K 2945
2023
Q4
$33.5K Buy
+12,798
New +$31K ﹤0.01% 2649
2018
Q1
Sell
-15,306
Closed -$40K 2656
2017
Q4
$40K Buy
+15,306
New +$47.8K ﹤0.01% 1560

Other funds holding APYX

Two Sigma Securities's APYX Position: Q1 2025 in Review

Two Sigma Securities sold out of Apyx Medical (APYX) in Q1 2025, closing a stake of 16,129 shares — an estimated $25.5K sold.

Two Sigma Securities first reported a position in APYX in Q4 2017 and held it in 4 quarters. The position peaked at $40K in Q4 2017. 43 funds tracked by Wall St. Rank hold APYX as of Q1 2025.

  • Two Sigma Securities reported no remaining Apyx Medical position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 16,129 Apyx Medical shares in Q1 2025, an estimated $25.5K.
  • Two Sigma Securities first reported a position in Apyx Medical in Q4 2017 and held it in 4 quarters.
  • Two Sigma Securities's Apyx Medical position peaked at $40K in Q4 2017.
  • 43 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.